China steps up pressure on GSK

UK drug giant GlaxoSmithKline (GSK.NYSE, GSK.LON) came under fire again as its allegedly detained employees told Chinese state-owned media that company executives created a culture to encourage corrupt practices, The Wall Street Journal reported. China’s national broadcaster on Tuesday aired reports featuring what it said were detained employees saying that managers pressured sales representatives to get drugs to Chinese customers faster. The Ministry of Public Security accused the company of bribing doctors, hospitals and government officials in July in an effort to sell more drugs at higher prices.